A planned mass cholera vaccination project in Haiti continues to be “bogged down in bureaucratic red tape,” as spring rains begin and the number of cholera cases starts to rise, NPR’s health blog “Shots” reports. The Haitian medical group GHESKIO and international health organization Partners In Health are organizing the vaccination campaign, which “is awaiting approval from a national ethics committee, which wants assurance that the vaccine is no longer considered experimental,” according to the news service, which notes the “WHO last November approved the dollar-a-dose vaccine that’s ready to be used in Haiti.”

NPR describes an ongoing education campaign to raise awareness of the disease and gauge public interest in the vaccine, as well as a cholera treatment center. “If the project does go forward, however, proponents will face another hurdle,” as “the planned vaccination project will reach only about one percent of the Haitian population,” NPR reports. However, “[t]o bring cholera under control, experts figure they’ll need to vaccinate millions of people at high risk of cholera — before next year’s rainy season,” the news service writes (Knox, 3/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.